Clinical Trial Update: Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dapsone in patients with aneurysmal subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Brain Ischemia
• Delayed Cerebral Ischemia
• Subarachnoid Hemorrhage
• Vasospasm Cerebral

Drugs mentioned

• DAPSONE (dapsone)

Snippet

Sponsor: El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | Conditions: Subarachnoid Hemorrhage, Brain Ischemia | Phase 3 | Status: COMPLETED